We are live on ! Find out more
GA

GuoLine Advisory Portfolio holdings

AUM $1.07B
1-Year Est. Return 26.27%
This Fund
S&P 500
This Quarter Est. Return
+13.13%
1 Year Est. Return
+26.27%
3 Year Est. Return
+81.88%
5 Year Est. Return
10 Year Est. Return
AUM
$632M
AUM Growth
+$125M
Cap. Flow
+$58.4M
Cap. Flow %
9.25%
Top 10 Hldgs %
82.64%
Holding
16
New
3
Increased
3
Reduced
1
Closed
1

Top Sells

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$18.7M
2
TW icon
Tradeweb Markets
TW
+$11.2M

Sector Composition

Rank Sector Weight
1 Technology 32.48%
2 Healthcare 28.48%
3 Financials 27.1%
4 Communication Services 9.96%
5 Industrials 1.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.45T
$86.2M 13.64%
229,100
AAPL icon
2
Apple
AAPL
$4.54T
$71.6M 11.33%
371,700
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.36T
$62.9M 9.96%
450,500
MA icon
4
Mastercard
MA
$502B
$48.2M 7.63%
113,000
TMO icon
5
Thermo Fisher Scientific
TMO
$213B
$47.8M 7.56%
90,000
GEHC icon
6
GE HealthCare
GEHC
$30.7B
$46.9M 7.43%
606,964
V icon
7
Visa
V
$684B
$46.9M 7.42%
180,000
SPGI icon
8
S&P Global
SPGI
$121B
$40.3M 6.37%
91,400
+31,800
+53% +$12.5M
AJG icon
9
Arthur J. Gallagher & Co
AJG
$64.1B
$35.9M 5.68%
159,600
+50,200
+46% +$11.9M
PANW icon
10
Palo Alto Networks
PANW
$270B
$35.6M 5.63%
241,200
ZTS icon
11
Zoetis
ZTS
$32.4B
$34.4M 5.45%
174,400
+34,900
+25% +$6.18M
VRTX icon
12
Vertex Pharmaceuticals
VRTX
$121B
$32.4M 5.13%
+79,700
New +$29.4M
NVO
13
Novo Nordisk
NVO
$208B
$18.4M 2.91%
+177,600
New +$17.6M
GE icon
14
GE Aerospace
GE
$374B
$12.5M 1.98%
122,794
-201,733
-62% -$18.7M
NOW icon
15
ServiceNow
NOW
$115B
$11.9M 1.89%
+84,500
New +$10.7M
TW icon
16
Tradeweb Markets
TW
$21.4B
-139,100
Closed -$11.2M

Similar funds

GuoLine Advisory's Q4 2023 Portfolio in Review

As of Q4 2023, GuoLine Advisory held 16 positions worth $632M, up 25% from $507M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

GuoLine Advisory deployed $58.4M of net new capital in Q4 2023, opening 3 new positions and adding to 3 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 79,700 shares worth $32.4M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was GE Aerospace, an estimated $18.7M trimmed.

  • GuoLine Advisory's largest Q4 2023 buy was Vertex Pharmaceuticals: 79,700 shares worth $32.4M.
  • GuoLine Advisory added most to S&P Global in Q4 2023, an estimated $12.5M increase.
  • GuoLine Advisory's biggest Q4 2023 reduction was GE Aerospace, cutting an estimated $18.7M.
  • GuoLine Advisory fully exited Tradeweb Markets in Q4 2023, selling an estimated $11.2M.
  • GuoLine Advisory's ten largest holdings make up 83% of its $632M portfolio in Q4 2023.
  • GuoLine Advisory opened 3 new positions and closed 1 in Q4 2023.
  • GuoLine Advisory's portfolio value rose 25% quarter-over-quarter to $632M.

Based on GuoLine Advisory's 13F filing for Q4 2023, filed 10 Jan 2024.